BOND

Evolve Enhanced Yield Bond Fund (BOND.U)

Market Closed
13 Jun, 20:00
TSX TSX
$
18. 46
+0.16
+0.87%
$
- Market Cap
1.56% Div Yield
0 Volume
$ 18.3
Previous Close
Day Range
18.46 18.46
Year Range
17.9 21.84
Want to track BOND.U and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BOND.U closed Friday higher at $18.46, an increase of 0.87% from Thursday's close, completing a monthly increase of 2.44% or $0.44. Over the past 12 months, BOND.U stock lost -2.48%.
BOND.U pays dividends to its shareholders, with the most recent payment made on Jul 03, 2025.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BOND.U Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
BOND: Another Attractive Opportunity From Pimco

BOND: Another Attractive Opportunity From Pimco

BOND has nearly doubled its AUM to $5.5 billion in the past two years and has outperformed its actively managed peers and passive benchmark. The fund primarily invests in investment-grade MBS bonds and Treasuries, with a portfolio duration of 6.5 years, placing it in the intermediate duration category. While BOND's annualized volatility of 7.4% is higher than the Bloomberg U.S. Aggregate Index's 5%, its superior total return performance suggests that the active management's risk-taking has been justified.

Seekingalpha | 2 weeks ago
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA

Globenewswire | 2 months ago
BOND: Questionable Exposure Outlook, Yet Probably A Hold Opportunity

BOND: Questionable Exposure Outlook, Yet Probably A Hold Opportunity

PIMCO Active Bond Exchange-Traded Fund ETF is in focus as a volatile credit environment sets the scene for active bond management. BOND ETF's commentary suggests it remains committed to intermediate term treasuries, CLOs, and RMBS. Moreover, recent enterprise-wide commentary suggests that PIMCO is seeking EU exposure. We support intermediate-to-long-term U.S. treasury and CLO exposure. However, we highlight risks in RMBS and dislike the vehicle's disregard of investment grade corporate credit.

Seekingalpha | 3 months ago

Evolve Enhanced Yield Bond Fund Dividends

BOND
BOND In 3 weeks
Estimated
Other
$0.39 Per Share
BOND
BOND 6 days ago
Paid
Other
$0.39 Per Share
BOND
BOND 1 month ago
Paid
Monthly
$0.4 Per Share
BOND
BOND 2 months ago
Paid
Monthly
$0.4 Per Share
BOND
BOND 3 months ago
Paid
Monthly
$0.38 Per Share
BOND
BOND 4 months ago
Paid
Monthly
$0.38 Per Share

Evolve Enhanced Yield Bond Fund Earnings

BOND.U have yet to publish their earning reports.
BOND
BOND In 3 weeks
Estimated
Other
$0.39 Per Share
BOND
BOND 6 days ago
Paid
Other
$0.39 Per Share
BOND
BOND 1 month ago
Paid
Monthly
$0.4 Per Share
BOND
BOND 2 months ago
Paid
Monthly
$0.4 Per Share
BOND
BOND 3 months ago
Paid
Monthly
$0.38 Per Share
BOND
BOND 4 months ago
Paid
Monthly
$0.38 Per Share
BOND.U have yet to publish their earning reports.

Evolve Enhanced Yield Bond Fund (BOND.U) FAQ

What is the stock price today?

The current price is $18.46.

On which exchange is it traded?

Evolve Enhanced Yield Bond Fund is listed on NYSE.

What is its stock symbol?

The ticker symbol is BOND.U.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.56%.

What is its market cap?

As of today, no market cap data is available.

Has Evolve Enhanced Yield Bond Fund ever had a stock split?

No, there has never been a stock split.

Evolve Enhanced Yield Bond Fund Profile

TSX Exchange
US Country

Overview

The described fund is an investment entity that focuses on deploying its assets across a broad range of fixed income securities with different maturity terms. Its investment strategy encompasses a heavy emphasis on ensuring at least 80% of its assets are invested in a diversified portfolio of fixed income instruments. These assets can be represented through various derivative forms, including forwards, options, futures contracts, or swap agreements, indicating a flexible approach to securing and leveraging debt securities. Predominantly, the fund invests in investment-grade debt securities, ensuring a stable and less risky investment environment. However, it retains the capability to diversify and potentially enhance returns by investing up to 30% of its total assets in high-yield securities. These high-yield investments are determined based on ratings from esteemed agencies such as Moody's, S&P, or Fitch or are otherwise internally assessed by PIMCO when not officially rated. Through this strategic balance, the fund seeks to achieve a blend of stability and growth by navigating the complex landscape of fixed income investments.

Products and Services

  • Fixed Income Instruments Portfolio

    The fund's primary offering is its diversified portfolio of Fixed Income Instruments, focusing on ensuring a stable and potentially lucrative investment. By including a varied maturity range of debt securities, it allows investors to balance risk and return effectively. This diversified approach aims at capital preservation while seeking returns through interest income and potential capital appreciation.

  • Derivative Financial Instruments

    A key component of the fund's investment strategy includes the use of forwards, options, futures contracts, or swap agreements. This allows the fund to hedge against potential losses, speculate on future movements in the fixed income markets, and increase the portfolio's overall exposure to desired asset classes or risk levels without necessarily increasing the capital at stake.

  • Investment Grade and High-Yield Securities

    The fund's allocations are predominantly within investment-grade debt securities, which are rated for quality and stability by renowned agencies such as Moody’s, S&P, or Fitch. This ensures that a significant portion of the fund’s assets is invested in lower-risk securities. Additionally, it offers an avenue for higher risk and potentially higher return investments through allocating up to 30% of its total assets in high-yield securities. This mix caters to investors looking for a balanced approach to fixed income investment, combining safety with the opportunity for increased yield.

Contact Information

Address: -
Phone: NA